What does ibrutinib capsules mainly treat? What is the effect?

Ibrutinib capsules, as an innovative oral small molecule drug, have demonstrated significant therapeutic effects in the treatment of hematological malignancies. It mainly acts on Bruton's tyrosine kinase (BTK) in B-cell lymphoma. By specifically binding and inhibiting the activity of BTK, it blocks the malignant proliferation and migration of B cells, thereby treating hematological malignancies.

Ibrutinib capsules have shown good efficacy in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in adult patients. Especially for those CLL/SLL patients with 17p deletion, ibrutinib capsules have become an important treatment option. This deficiency is often associated with disease progression and poor prognosis, and ibrutinib capsules can significantly extend patients' progression-free survival and improve their quality of life.

In addition, ibrutinib capsules have achieved remarkable results in the treatment of Waldenstrom's macroglobulinemia (WM) in adult patients. WM is a rare hematological malignancy, and patients often require multiple lines of treatment. The introduction of ibrutinib capsules provides a new treatment option for WM patients, and its efficacy and safety have been widely recognized.

What is more worth mentioning is that ibrutinib capsules are also approved for the treatment of chronic graft-versus-host disease (cGVHD) in adult and pediatric patients 1 year and older after failure of one or more systemic treatments. This is the first Bruton's tyrosine kinase inhibitor (BTKi) treatment approved for use in pediatric patients, marking the further expansion of ibrutinib capsules in the field of immunotherapy.

In short, ibrutinib capsule, as an efficient and safe treatment for hematological malignancies, has demonstrated remarkable efficacy in many fields. Currently, the China Food and Drug Administration has approved ibrutinib for marketing. Please consult your local hospital pharmacy for specific pricing. There are also some affordable generic drugs sold overseas, providing patients with multiple choices.